Contract Research
WuXi XDC Partners with IntoCell to Boost ADC Discovery and Development
Under the agreement, IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate (OHPASTM) Linker and novel...
January 03, 2024 | News
Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome
Highlights: Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures Improvements were con...
December 19, 2023 | News
Merck Expands Newest Biologics Testing Center in Shanghai
Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...
November 30, 2023 | News
Is Asia ready to be the next global biotech hub?
As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...
November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...
November 20, 2023 | News
XINGIMAGING and MITRO BIOTECH Merge for Global CRO Operations
As a combined company, Mitro will expand its capabilities to provide full CRO services, including clinical and clinical imaging management, in China&n...
October 24, 2023 | News
Cameron Smith Appointed as Chief Business Development Officer for Agilex Biolabs
Cameron brings a wealth of experience in the Bioanalytical field, with a particular focus on Toxicology. His extensive knowledge and global market expertis...
October 17, 2023 | News
Navin Fluorine International Ltd. unveils "Navin Molecular" as the new brand for its innovative CDMO business
The new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions. Firstly, ...
October 17, 2023 | News
WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration
ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...
October 13, 2023 | News
Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma
In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...
October 11, 2023 | News
Emmes acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...
October 06, 2023 | News
WuXi Bio Applauds Amicus on FDA Approval for Pompe Disease Therapy
Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...
October 02, 2023 | News
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticit...
September 27, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
